Presented by: Paul Reynolds, PhD
Original Publication Date: November 14, 2025 (AAOSH Accelerate 2025)
|
Take the Course - Coming Soon |
This course is available for CE Credit as a "Members Only" benefit. Not a Member? CLICK HERE to learn more about AAOSH Membership. |
Course Description:
Chronic low-grade inflammation is now recognized as a root driver of most modern diseases, including cardiovascular disease, diabetes, obesity, fatty liver, dementia, and autoimmune disorders. A central instigator of this inflammation is glycation—the non-enzymatic bonding of glucose to proteins and lipids that generates advanced glycation end products (AGEs). These AGEs trigger oxidative stress, impair cellular function, and amplify inflammatory signaling across multiple tissues.
This presentation will explore the mechanistic links between dietary carbohydrates, insulin resistance, and the cascade of glycation and inflammation that drives chronic disease. Special attention will be given to lifestyle interventions—particularly carbohydrate control and intermittent fasting—as practical, evidence-based strategies to reduce glycation burden and systemic inflammation.
Finally, emerging research on xylitol will be discussed, highlighting its unique capacity to lower postprandial glucose, mitigate glycation, and support mucosal and microbiome health across nasal, oral, and gut systems. Collectively, these findings suggest that addressing glycation and inflammation at their metabolic origins may represent one of the most promising frontiers in preventive and integrative health care.
Learning Objectives:
Upon completion of this lecture, participants will be able to:
Practical Applications:
Method: Lecture
Location: Online (Zoom)
AGD Course Code: 1010 (Basic Science)
Credit Hours: 1
Speaker's Bio:
Dr. Paul Reynolds earned a PhD in molecular and developmental biology. As a professor at Brigham Young University, he primarily studies the effects of inflammation and glycation. His research explores the pulmonary apparatus (exposure to particulates and how exposure influences systemic health) and inflammation caused by hyperglycemia and how ketogenic states mitigate inflammatory outcomes. His research program has received numerous grants from private institutes and the National Institutes of Health.
Conflict of Interest:
N/A